Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories (NY: BIO )

516.56 USD UNCHANGED
Streaming Delayed Price Updated: 4:26 AM EST, Nov 25, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2
Open 516.56
Bid (Size) 505.50 (1)
Ask (Size) 525.00 (1)
Prev. Close 516.56
Today's Range 516.56 - 516.56
52wk Range 309.38 - 648.39
Shares Outstanding 24,701,407
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
5 Value Stocks To Watch In The Healthcare Sector
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that ... 
Tags News BIIB AMRX
From Benzinga
Thinking about trading options or stock in Farfetch, Carnival Corp, General Electric, Tilray, or Bio-Rad Laboratories?
InvestorsObserver issues critical PriceWatch Alerts for FTCH, CCL, GE, TLRY, and BIO. 
From PR Newswire

Performance

YTD
+38.80%
+38.80%
1 Month
-11.52%
-11.52%
3 Month
+0.89%
+0.89%
6 Month
+7.36%
+7.36%
1 Year
+40.05%
+40.05%

More News

Read More
Strange: Bullish BIO Analysts Actually See -12.97% Downside
Tags ETFs
From ETF Channel
Bio-Rad Reports Third-Quarter 2020 Financial Results
From Business Wire News Releases
Bio-Rad Laboratories: Q3 Earnings Insights
Tags BIO Market News Benzinga
From Benzinga
Composite Rating For Bio Rad Labs Jumps To 96
From Investor's Business Daily
IPO Outlook: Insurance Cos., Mortgage Providers, Leslie's Pool Supplies Highlight This Week's Offerings
Tags Voxtel GATO News
From Benzinga
The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies
Tags SUPN YMAB FLGT
From Benzinga
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
Tags REPL BLFS LH
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
Tags LHCG ROK RPD
From Benzinga
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Tags BIO BDSI GTHX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.